Description

n-[[(1S)-11-Bromo-1,2,7,8,13,13Bβ-Hexahydro-10-Hydroxy[1,6,2]Oxathiazepino[2',3':1,2]Pyrido[3,4-B]Indol]-1α-Yl]-2-Hydroxyacetamide is a complex, high-purity heterocyclic organic compound featuring a fused oxathiazepino-pyridoindole core structure. This molecule is of significant interest for its potential as a key synthetic intermediate or a pharmacologically active scaffold in advanced research and development. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical synthesis facilities engaged in the discovery of novel therapeutic agents.

Application

• Pharmaceutical Research & Development: Serves as a critical building block or lead compound in the synthesis of novel drug candidates targeting central nervous system (CNS) disorders, oncology, or other therapeutic areas.
• Medicinal Chemistry: Used for structure-activity relationship (SAR) studies to optimize biological activity and pharmacokinetic properties of new chemical entities.
• Process Chemistry Development: Employed in the scale-up and optimization of synthetic routes for potential active pharmaceutical ingredients (APIs).
• Biochemical Research: May be utilized as a tool compound or probe to investigate specific enzyme interactions or biological pathways in academic and industrial settings.
• Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for the production of specialized intermediates under cGMP or research-grade conditions.

Basic Information

Item	Detail
Product Name	n-[[(1S)-11-Bromo-1,2,7,8,13,13Bβ-Hexahydro-10-Hydroxy[1,6,2]Oxathiazepino[2',3':1,2]Pyrido[3,4-B]Indol]-1α-Yl]-2-Hydroxyacetamide
CAS No.	96426-93-6
Molecular Formula	C19H18BrN3O4S
Molecular Weight	464.33 g/mol
Synonyms	11-Bromo-1,2,7,8,13,13b-hexahydro-10-hydroxy[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indol-1α-yl-2-hydroxyacetamide; (1S)-11-Bromo-1,2,7,8,13,13b-hexahydro-10-hydroxy[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indol-1α-yl-2-hydroxyacetamide; Bromo-oxathiazepino-pyridoindole acetamide derivative; 96426-93-6; UNII-Contact for details
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Each batch undergoes comprehensive analytical characterization using techniques such as HPLC, NMR, and MS to ensure identity, purity, and consistency. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting critical quality attributes. We support development from research to commercial scale with appropriate quality standards, including potential cGMP compliance for designated batches.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as specified on the label or COA. This compound is likely light-sensitive and may be hygroscopic; store in a cool, dry place under an inert atmosphere if specified. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC/MS)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0% (Research Grade)
Purity (HPLC)	≥ 98.0% (Advanced Intermediate Grade)
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.